Lymphoma Clinical Trials
Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.
If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.
SWOG S1608 - "Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma"
CANCER TYPE: Non-Hodgkin's
RESEARCH BASE: SWOG
NCT NUMBER: NCT03269669
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
UPDATED ON 07/27/2018 (16:05:02)
Relapsing or refractory follicular lymphoma, grade I, II, IIIa, Obinutuzumab + TGR-1202 or Lenalidomide or CHOP